Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'

Eur J Heart Fail. 2021 Apr;23(4):681-682. doi: 10.1002/ejhf.2049. Epub 2020 Nov 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzoxazoles
  • Cardiomyopathies*
  • Heart Failure*
  • Humans
  • Prealbumin

Substances

  • Benzoxazoles
  • Prealbumin
  • tafamidis